Royalty Report: Drugs, Therapeutic, Biotechnology – Collection: 4320

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Therapeutic
  • Biotechnology
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 4320

License Grant
The Licensee entered into a license agreement with the Licensor, a University.  The Licensee received exclusive license to the technology patented by the Licensee.
License Property
The License relates to the technology patented by Yale entitled “Circulating hypomethylated B cell derived DNA as a biomarker of B cell destruction.”
Field of Use
The Licensee is a clinical stage company engaged in the research, development and commercialization of therapeutics in the field of diabetes.

IPSCIO Record ID: 7269

License Grant
The Licensee entered into a licensing agreement with the University to license certain patents and technology.
License Property
The License relates to certain methods using probe-based PCR detection to measure levels of circulation demethylated ß cell derived DNA as a measure of ß cell loss in diabetes.
Field of Use
The Licensee is a clinical stage company engaged in the research, development and commercialization of therapeutics in the field of diabetes.

IPSCIO Record ID: 7441

License Grant
The University grants the Licensee an exclusive license, under the Licensed Patents to make, have made, use, sell, have sold, import or export Licensed Products and to practice any licensed method, within the field in the licensed territory.
License Property
The Invention is patent 61/510,812 entitled “Endometrial Derived Stem Cells to Treat Diabetes.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.